PainReform Ltd. 2022 Investor Presentation Post-Operative Pain

PainReform Ltd. is a clinical-stage biopharmaceutical company developing PRF-110, a novel product candidate for post-operative pain management. The presentation outlines the company's forward-looking strategy, experienced management team with deep biotech credentials, and product development trajectory.